Phenergan (Promethazine) in Pregnancy: Safety by Trimester and Alternatives

Phenergan® (promethazine) is a first-generation antihistamine (H1 antagonist) with antiemetic, sedative, and anticholinergic properties. Used for nausea/vomiting of pregnancy (NVP), hyperemesis gravidarum, and allergic conditions.

FDA Pregnancy Category: C (Old System) / Pregnancy and Lactation Labeling Rule (PLLR) Data

  • First trimester: No increased major malformation risk in large cohort studies (e.g., Nordic registries, ~10,000 exposures). Considered compatible when benefits outweigh risks.
  • Second/Third trimester: Concerns shift to neonatal effects:
    • Sedation, respiratory depression, irritability, extrapyramidal symptoms (EPS) if used near term.
    • Platelet aggregation inhibition (theoretical bleeding risk).
    • Potential for neonatal withdrawal with chronic high-dose use.
  • Labor and delivery: Avoid routine use; may cause neonatal CNS depression. If used for NVP, discontinue 24–48h before anticipated delivery if possible.

Clinical Guidelines (ACOG, SMFM)

  • First-line for NVP: Pyridoxine (B6) ± doxylamine (Diclegis®/Bonjesta® — FDA-approved, Category A).
  • Second-line: Promethazine, metoclopramide, ondansetron (controversial re: cardiac defects; recent data reassuring).
  • Severe hyperemesis: IV hydration, thiamine, corticosteroids (methylprednisolone), promethazine as adjunct.

Risk-Benefit Considerations

  • Maternal benefit: Dehydration, weight loss, electrolyte imbalance, Wernicke's encephalopathy prevention.
  • Fetal/neonatal risk: Low absolute risk; mostly transient neonatal sedation/EPS.
  • Shared decision-making: Discuss severity, alternatives, gestational age, patient values.

Breastfeeding

Promethazine excreted in milk; infant sedation reported. Preferred alternatives: loratadine, cetirizine (non-sedating). If promethazine needed, monitor infant for drowsiness; consider timing dose after feeding.

Key Takeaway

Promethazine is not contraindicated in pregnancy but is not first-line for NVP. Use lowest effective dose, shortest duration, avoid near term. Always consult OB provider before starting/stopping.

Pregnancy & Health - Related Articles